Controversies in Cardiac Surgical ICU Staffing (STS/SCA Joint Session)
Unless otherwise noted, speakers have nothing to disclose.
Moderators
Nicholas Teman, MD
James Abernathy, MD, MPH, FASE, FAHA
Disclosure: Becton Dickinson: Advisory Board (Ongoing)
Presentations
- Cardiac ICUs Should Use Open Staffing Models
Andrew D. Shaw, MD
Disclosure: AMPharma: Advisory Board (Ongoing); Edwards Lifesciences: Advisory Board (Ongoing); Fresenius: Advisory Board (Ongoing); Novartis: Advisory Board (Ongoing)
- Cardiac ICUs Should Use Closed Staffing Models
Glenn Whitman, MD
Disclosure: Avania/Cellphire: Advisory Board (Ongoing); GWBN LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing)
- Extubation in the Operating Room following Cardiac Surgery – Not so Fast
Eric W. Etchill, MD, MPH
- The Ideal CVSICU Multidisciplinary Team
Anna L. Ciullo, MD
- 24/7 CVSICU Intensivist Coverage: What's the Data?
Rakesh C. Arora, MD, PhD, FRCSC
Disclosure: Edwards Life Sciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); HLS therapeutics: Advisory Board (Terminated, September 22, 2022)
- Panel Discussion
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Price
Cost:
$0.00
Unless otherwise noted, speakers have nothing to disclose.
Moderators
Nicholas Teman, MD
James Abernathy, MD, MPH, FASE, FAHA
Disclosure: Becton Dickinson: Advisory Board (Ongoing)
Presentations
- Cardiac ICUs Should Use Open Staffing Models
Andrew D. Shaw, MD
Disclosure: AMPharma: Advisory Board (Ongoing); Edwards Lifesciences: Advisory Board (Ongoing); Fresenius: Advisory Board (Ongoing); Novartis: Advisory Board (Ongoing)
- Cardiac ICUs Should Use Closed Staffing Models
Glenn Whitman, MD
Disclosure: Avania/Cellphire: Advisory Board (Ongoing); GWBN LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing)
- Extubation in the Operating Room following Cardiac Surgery – Not so Fast
Eric W. Etchill, MD, MPH
- The Ideal CVSICU Multidisciplinary Team
Anna L. Ciullo, MD
- 24/7 CVSICU Intensivist Coverage: What's the Data?
Rakesh C. Arora, MD, PhD, FRCSC
Disclosure: Edwards Life Sciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); HLS therapeutics: Advisory Board (Terminated, September 22, 2022)
- Panel Discussion